Benefits of Point-of-Care Testing in Community Pharmacy Practice

Opinion
Video

A panelist discusses how implementing point-of-care testing in community pharmacies can be a significant revenue driver while creating a destination point for patients to receive health care services, especially in areas with limited access to providers.

Introduction and Value Proposition

Main Discussion Topics:

  • Point-of-care testing as a revenue driver for community pharmacies
  • Addressing health care deserts through accessible pharmacy services
  • Strengthening provider relationships through complementary care

Key Points for Physicians:

  • Point-of-care testing in pharmacies can complement physician care
  • Services include COVID-19, influenza, streptococcal infection, hemoglobin A1c, and cholesterol testing
  • Pharmacies see patients approximately 33 times annually vs 3 physician visits

Notable Insights:

  • Independent consultant Deloitte predicts point-of-care testing will exceed immunizations as a revenue driver in community pharmacies
  • Revenue comparison: one $90 point-of-care test equals profit from approximately 90 prescriptions
  • Approximately 52% of the population lacks adequate access to health care

Clinical Significance:

Point-of-care testing in pharmacies represents a transformational opportunity to extend health care access, improve patient outcomes, and create sustainable clinical service revenue while strengthening collaborative care models between pharmacists and physicians.

Recent Videos
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.